Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
Holding ACRS?
Track your performance easily

Aclaris Therapeutics (ACRS) Income Statement

587 Followers

Aclaris Therapeutics Income Statement

Last quarter (Q3 2024), Aclaris Therapeutics's total revenue was $4.35M, a decrease of -53.18% from the same quarter last year. In Q3, Aclaris Therapeutics's net income was $-7.59M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 27.08M$ 31.25M$ 29.75M$ 6.76M$ 6.48M$ 4.23M
Cost of Revenue
$ 9.58M$ 18.08M$ 11.96M$ 4.71M$ 5.13M$ 4.05M
Gross Profit
$ 17.50M$ 13.17M$ 17.79M$ 2.05M$ 1.35M$ 172.00K
Operating Expense
$ 79.05M$ 129.48M$ 102.95M$ 67.43M$ 49.87M$ 92.73M
Operating Income
$ -46.30M$ -97.36M$ -89.85M$ -89.72M$ -50.91M$ -111.06M
Net Non Operating Interest Income Expense
$ 1.99M-$ -4.02M-$ -5.00K$ -87.00K
Other Income Expense
$ -22.81M$ 27.47M$ -1.75M$ 25.48M$ 2.82M$ 6.54M
Pretax Income
$ -50.15M$ -88.85M$ -86.91M$ -90.86M$ -51.34M$ -113.54M
Tax Provision
$ -367.00K$ -367.00K--$ -182.00K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -37.00M$ -88.48M$ -86.91M$ -90.86M$ -51.02M$ -113.54M
Basic EPS
$ -0.52$ -1.27$ -1.33$ -1.60$ -1.20$ -3.90
Diluted EPS
$ -0.52$ -1.27$ -1.33$ -1.60$ -1.20$ -3.90
Basic Average Shares
$ 284.67M$ 69.81M$ 65.21M$ 56.73M$ 42.54M$ 41.32M
Diluted Average Shares
$ 284.67M$ 69.81M$ 65.21M$ 56.73M-$ 41.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 81.86M$ 147.56M$ 114.91M$ 72.14M$ 55.00M$ 96.78M
Net Income From Continuing And Discontinued Operation
$ -37.00M$ -88.48M$ -86.91M$ -90.86M$ -51.02M$ -161.35M
Normalized Income
$ -63.03M$ -106.39M----
Interest Expense
------
EBIT
$ -58.20M$ -116.31M$ -85.15M$ -65.38M$ -48.52M$ -113.45M
EBITDA
$ -57.31M$ -115.45M$ -84.36M$ -64.46M$ -47.20M$ -107.05M
Currency in USD

Aclaris Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis